Assessing functionality changes associated with patients who were taking short acting opioids chronically and who initiated treatment with Duragesic (fentanyl transdermal system) for the management of chronic low back pain

Trial Profile

Assessing functionality changes associated with patients who were taking short acting opioids chronically and who initiated treatment with Duragesic (fentanyl transdermal system) for the management of chronic low back pain

Completed
Phase of Trial: Phase III

Latest Information Update: 15 May 2007

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Back pain
  • Focus Therapeutic Use
  • Sponsors Ortho-McNeil
  • Most Recent Events

    • 15 May 2007 Status changed from in progress to completed.
    • 18 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top